We’re proud and delighted to be announced as the winner of the SME Business of the Year Award and thank the judges for recognising PHARMExcel as an exceptional business driving innovation and outstanding service in the drug development sector.
The esteemed Award is one of the most credible and highly valued recognition for small to
medium-sized businesses operating in Hertfordshire, UK.
The Award is an accolade to an impressive year for PHARMExcel. Recognised as a major player in early phase clinical trials, the company continues to grow from strength to strength. In the last 12 months the Contract Research Organisation (CRO) played a pivotal role in the world’s first COVID booster vaccination trial (Covboost) and the first into-man safety and performance trial of a new liver dialysis device study-DIALIVETM .
Commenting on the Award, Yvanne Enever, CEO at PHARMExcel, says: “To win this award is testimony to the fantastic work our team does every single day. Since I founded the company 13 years ago PHARMExcel has experienced unprecedented growth and success driven by the hard work and commitment of everyone across the business and the exceptional service we always deliver.”
It was also a night of double celebrations for the PHARMExcel team. In addition to winning gold for best business of the year, Yvanne Enever, Founder and CEO of PHARMExcel was awarded Businesswoman of the Year honours.
Among the eight finalists Yvanne was recognised for her exceptional business leadership and drive which has seen the company grow three-fold in the last 12 months.
Read the full announcement here.
Yvanne said: “One of the values of PHARMExcel is quality. We place a huge importance on ensuring we have the right expertise, systems and approach to successfully manage clinical trials end to end, regardless of size. To come away with these two gold awards proves that we are getting it right.”
PHARMExcel is an award-winning, full-service Contract Research Organisation (CRO) providing a flexible and innovative approach to clinical trial delivery. The company is recognised for its in-depth knowledge and experience of the clinical research environment, particularly in the UK, and has a network of regulatory and industry associates, allowing it to provide a global reach.
Media contact: Yvanne.Enever@pharmexcel-cro.com
Tel: +44 (0) 2036426654
